Professional Documents
Culture Documents
Chronic Obstructive Pulmonary Disease
Chronic Obstructive Pulmonary Disease
patient imprint
PHYSICIAN'S ORDER SHEET
Chronic Obstructive Pulmonary Disease
Another brand of a generically equivalent product identical in dosage
form and content of active ingredient may be administered unless
indicated.
Chronic Obstructive Pulmonary Disease
Admit Location c Blood gas, venous now if not done and ________.
d
e
f
g
c Admit to location __________________
d
e
f
g Source
Admission Status c Ventilator settings Evidence
d
e
f
g
c Admit to inpatient to Dr. ______service.
d
e
f
g c Please record autopeep on vent.
d
e
f
g
c Admit to observation to Dr. _________ service.
d
e
f
g Diet
Code Status g NPO / NPO except po meds with sips.
c
d
e
f
c Resuscitation status Full Code
d
e
f
g c Clear liquids
d
e
f
g
c Resuscitation status Do Not Resuscitate / Do Not
d
e
f
g c Regular diet
d
e
f
g
Intubate (allow natural death) c Therapeutic diet ____________.
d
e
f
g
There is inconclusive evidence to support the use of
c Resuscitation status Partial Code
d
e
f
g
nutritional supplementation in patients with chronic
Vital Signs obstructive pulmonary disease Evidence
c Vitals per unit protocol
d
e
f
g IV Fluids
c Vital signs every_____hour and then
d
e
f
g
every_____________ c Dextrose 5% with 0.9% NaCl @ _____mL/hr for 24
d
e
f
g
hours.
Pulse oximetry
c Dextrose 5% with 0.45% NaCl @ _____mL/hr for 24
d
e
f
g
c
d
e
f
g Continuous
hours.
c Spot every shift and prn
d
e
f
g
c Sodium Chloride 0.9% @ ______mL/hr for 24 hours.
d
e
f
g
Activity
c Additives ______________________
d
e
f
g
c Ambulate with assistance every 8 hours.
d
e
f
g c Saline lock.
d
e
f
g
c Bed rest with bedside commode
d
e
f
g Medications
c Bed rest
d
e
f
g Antibacterial Agents Evidence
c Up ad lib to ______.
d
e
f
g Consider the administration of antimicrobial therapy
Nursing Orders Evidence
Assessments c cefTRIAXone /ROCEPHIN 1 gram intravenously once a
d
e
f
g
c Glucose, blood, fingerstick. _______ One Time. Other
d
e
f
g day
Frequency _______________ c azithromycin /ZITHROMAX 500 milligram
d
e
f
g
c Measure and document intake and output Total for
d
e
f
g intravenously once a day
every 8 hours c clarithromycin /BIAXIN 500 milligram orally every 12
d
e
f
g
c Measure weight
d
e
f
g hours with food.
Contingency c levofloxacin /LEVAQUIN 500 milligram intravenously
d
e
f
g
c Notify provider specify parameters temp > 101; HR <
d
e
f
g once a day
60 or > 120, RR < 8 or > 30, SBP < 90 or > 180; UO c levofloxacin /LEVAQUIN 750 milligram intravenously
d
e
f
g
< 120 in 4 hours once a day
Interventions Bronchodilators
c Elevate head of bed to ______ degrees.
d
e
f
g Spiriva and Atrovent should not be used concurrently
c Urinary catheter initiation/management
d
e
f
g c albuterol /PROVENTIL 2.5/5 milligram by nebulizer
d
e
f
g
c Urinary straight catheterization
d
e
f
g every ____hours
Respiratory c ipratropium /ATROVENT 500 microgram by nebulizer
d
e
f
g
every ___hours
c Oxygen via __________@ _____ to maintain O2 sat at
d
e
f
g
90% or greater. Evidence c
d
e
f
g Magnesium sulfate 2 g IVPB over 20 minutes Source
Corticosteroids
c Biphasic positive airway pressure (BIPAP) Evidence
d
e
f
g
c Inhaled steroid
d
e
f
g
c Biphasic positive airway pressure (BIPAP) Biphasic
d
e
f
g
budesonide 0.5 mg/2 ml neb solution /PULMICORT
positive airway pressure (BIPAP) with heliox bleedin
every 12 hours
Source
Systemic Corticosteroids Evidence
c
d
e
f
g Continuous positive airway pressure (CPAP) Evidence
Consider the administration of a systemic
c Blood gas, arterial now if not done and ________.
d
e
f
g corticosteroid
Evidence
Order Initiated By: _________________________ Date/Time: _______________
Physician Signature: ________________________ Date/Time: _______________
Released: April 2, 2009
Telephone/Verbal Orders: gc Read Back g
d
e
f c Confirmed
d
e
f Page &p of &P
patient imprint
PHYSICIAN'S ORDER SHEET
Another brand of a generically equivalent product identical in dosage
form and content of active ingredient may be administered unless
indicated.
c dexamethasone/DECADRON ___ mg IVP every ___
d
e
f
g Consider renal impairment when deciding on doses of
hours LMWH, the direct thrombin inhibitors, and other
c methylPREDNISolone /SOLUMEDROL ____ milligram
d
e
f
g antithrombotic drugs that are cleared by the kidneys,
intravenously every ____hours particularly in elderly patients and those who are at high
c predniSONE /STERAPRED ____ milligram orally
d
e
f
g risk for bleeding.
once a day In acutely ill medical patients who have been admitted
Analgesics to the hospital with CHF or severe respiratory disease,
Opioids Evidence or who are confined to bed and have one or more
c morphine 2 milligram intravenously every 4 hours
d
e
f
g adtioanla risk factors, inclujding active CA, previous
as needed for shortness of breath or wheezing VTE, sepsis, acute neurologic disease, or inflammatory
bowel disease, prophylaxis with LDUH or LMWH is
c morphine 15 milligram capsule, sustained release
d
e
f
g
orally 2 times a day as needed for shortness of recommended. In meidcal patients with risk factors for
breath or wheezing VTE in whom there is a contraindication to anticoagulant
Antipyretics prophylaxis, GCS or IPC is recommended.
c acetaminophen /TYLENOL 650 milligram orally or
d
e
f
g c
d
e
f
g Early and persistant mobilization
rectally every 4 hours as needed for fever >100.4 c
d
e
f
g Graded compression stockings (1530 mm Hg of
pressure at the ankle)
c acetaminophen /TYLENOL 650 milligram orally or
d
e
f
g
rectally every 6 hours as needed for fever greater c Sequential Compression Device
d
e
f
g
than 100.4 c CBC every other day starting on day 4 of heparin
d
e
f
g
Laxatives therapy thru day 14 or until Unfractionated
c magnesium hydroxide /MILK OF MAGNESIA 30
d
e
f
g heparin/LMWH is discontinued.
milliliter orally once a day as needed for constipation LowDose Unfractionated Heparin
c docusate sodium /COLACE 100 milligram orally 2
d
e
f
g c heparin 5,000 unit subcutaneously every 8 hours
d
e
f
g
times a day LowMolecularWeight Heparins
c bisacodyl /DULCOLAX 5 milligram orally once a day as
d
e
f
g c enoxaparin /LOVENOX 40 milligram subcutaneously
d
e
f
g
needed for constipation once a day
c bisacodyl /DULCOLAX 10 milligram suppository
d
e
f
g Reminders
rectally once a day as needed for constipation Avoid the routine use of parenteral betaagonists in
Sedatives Evidence patients with acute exacerbation of chronic obstructive
c LORazepam /ATIVAN 1 milligram intravenously every
d
e
f
g pulmonary disease Evidence
6 hours as needed for sedation Stress Ulcer Prophylaxis
c LORazepam /ATIVAN 1 milligram orally 2 times a day
d
e
f
g c Initiate Stress Ulcer Prophylaxis Protocol
d
e
f
g
as needed for sedation
Diagnostic Tests
c zolpidem /AMBIEN 5 milligram orally once a day, at
d
e
f
g
bedtime as needed for insomnia c 12lead ECG Evidence
d
e
f
g
c
d
e
f
g zolpidem /AMBIEN 10 milligram orally once a day, at c Radiograph, chest, 1 view Evidence
d
e
f
g
bedtime as needed for insomnia Laboratory
Smoking Cessation Medications Evidence c Complete blood cell count with automated white blood
d
e
f
g
c nicotine 7 mg/24 hr transdermal film, extended
d
e
f
g cell differential Evidence
release 1 patch transdermally once a day c Complete blood cell count with manual differential.
d
e
f
g
c nicotine 14 mg/24 hr transdermal film, extended
d
e
f
g c Basic metabolic panel
d
e
f
g
release 1 patch transdermally once a day c Comprehensive metabolic panel
d
e
f
g
c nicotine 21 mg/24 hr transdermal film, extended
d
e
f
g c Magnesium (Mg) level, serum
d
e
f
g
release 1 patch transdermally once a day c Phosphorus level, serum
d
e
f
g
DVT Prophylaxis c Eosinophil count
d
e
f
g
Mechanical methods of prophylaxis should be used Physician Consults
primarily in patients who are at high risk of bleeding or
c Consult to pulmonology
d
e
f
g
as an adjunct to anticoagulantbased prophylaxis.
c Consult to cardiology
d
e
f
g
Consults
c Consult to pulmonary rehabilitation Evidence
d
e
f
g
Order Initiated By: _________________________ Date/Time: _______________
Physician Signature: ________________________ Date/Time: _______________
Released: April 2, 2009
Telephone/Verbal Orders: gc Read Back g
d
e
f c Confirmed
d
e
f Page &p of &P
patient imprint
PHYSICIAN'S ORDER SHEET
Another brand of a generically equivalent product identical in dosage
form and content of active ingredient may be administered unless
indicated.
Other:________________________________
c Consult to Palliative Care
d
e
f
g
Order Initiated By: _________________________ Date/Time: _______________
Physician Signature: ________________________ Date/Time: _______________
Released: April 2, 2009
Telephone/Verbal Orders: gc Read Back g
d
e
f c Confirmed
d
e
f Page &p of &P
Print Only Selected Items Print All